Clinical Trial Update: Multipeptide Vaccine for Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from the University of Pennsylvania evaluating a multipeptide vaccine for advanced breast cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Multipeptide vaccine (multipeptide vaccine)

Snippet

Sponsor: University of Pennsylvania | Conditions: Breast Neoplasm, Breast Cancer | Phase 1 | Status: COMPLETED